Evaluation of Lungs of Normal Individuals by Lung Lavage, Brushing and Bronchial Wall Biopsy
| Status: | Completed |
|---|---|
| Conditions: | Smoking Cessation, Pulmonary |
| Therapuetic Areas: | Pulmonary / Respiratory Diseases |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 11/18/2012 |
| Start Date: | January 2004 |
| End Date: | January 2014 |
| Contact: | Charleen Hollmann, PhD, MPA, RN |
| Email: | chollman@med.cornell.edu |
| Phone: | (646) 962 2672 |
Evaluation of the Lungs of Normal Individuals With Segmental Bronchopulmonary Lung Lavage, Bronchial Brushing and Bronchial Wall Biopsy
The purpose of this study is to obtain biologic materials from the blood and lungs of normal
individuals to establish a set of normal range for various parameters. These will provide
important information when applied to individuals with various pulmonary diseases, and will
help in understanding of the etiology and pathogenesis of various lung diseases.
Study procedures will be performed at the Weill Cornell Medical College-New York
Presbyterian Hospital and/or Weill Greenburg York Avenue Building. Study procedures done
elsewhere that are within the protocol timeframe will be accepted if seen fit by the
investigators so that they are not repeated unnecessarily. Study individuals who undergo
bronchoscopy with intravenous administration of sedatives and analgesia may be required to
stay overnight. Bronchoscopy is normally an ambulatory procedure. The subject is observed
after the bronchoscopy, including vital signs and level of consciousness, until they are
back to baseline. An overnight stay would only be required if the individual was not, in the
judgment of the attending physician, safe to be discharged as is standard practice. Follow
up of all participants are carried out by telephone within 1 wk following the procedure.
Rockefeller University has been added as a second site.
Individuals undergoing bronchoscopy without intravenous administration of sedatives and
analgesia are not required to stay overnight due to the lack of administration of
CNS-altering drugs and the limited sampling involved (tracheal brushes only).
Inclusion Criteria:
- All study subjects should be able to provide informed consent
- Males or females ages 18 years and older.
- Must provide HIV informed consent.
- Non-smokers, ex-smokers and smokers.
Exclusion Criteria:
- Individuals not deemed in good overall health by the investigator will not be
accepted into the study.
- Drug and/or alcohol abuse within the past six months.
- Individuals with history of chronic lung disease, including asthma or with recurrent
or recent (within three months) acute pulmonary disease will not be accepted into the
study.
- Individuals with allergies to atropine or any local anesthetic will not be accepted
into the study.
- Individuals with allergies to pilocarpine, isoproterenol, terbutaline, atropine or
aminophylline will not be accepted into the study
- Females who are pregnant or nursing will not be accepted into the study
We found this trial at
1
site
Click here to add this to my saved trials
